2012

• Cui, P., Rawling, T., Bourget, K., Kim, T., Duke, C., Doddareddy, M., Hibbs, D., Zhou, F., Tattam, B., Petrovic, N., Murray, M. (2012), Antiproliferative and Antimigratory Actions of Synthetic Long Chain n-3 Monounsaturated Fatty Acids in Breast Cancer Cells That Overexpress Cyclooxygenase-2. Journal of Medicinal Chemistry. 55(16), 7163-7172. [Abstract]
• Murray, M. (2012), Toxicological actions of plant-derived and anthropogenic methylenedioxyphenyl-substituted chemicals in mammals and insects. Journal of Toxicology and Environmental Health. Part B, Critical Reviews. 15(6), 365-395. [Abstract]
• Ghassabian, S., Rawling, T., Zhou, F., Doddareddy, M., Tattam, B., Hibbs, D., Edwards, R., Cui, P., Murray, M. (2012), Role of human CYP3A4 in the biotransformation of sorafenib to its major oxidized metabolites. Biochemical Pharmacology. 84(2), 215-223. [Abstract]
• Rawling, T., McDonagh, A., Tattam, B., Murray, M. (2012), Synthesis of unsymmetrical biaryl ureas from N-carbamoylimidazoles: kinetics and application. Tetrahedron. 68(30), 6065-6070.
• Armour, C., Chaar, B., Murray, M., Ambler, G., Krass, I. (2012), Current therapies and pharmacy programs for obesity and diabetes. In: A Modern Epidemic. (pp.315-338).Australia: Sydney University Press.

2011

• Toh, D., Murray, M., Pern, T., Mulay, V., Grewal, T., Lee, E., Zhou, F. (2011), Functional analysis of pharmacogenetic variants of human organic cation/carnitine transporter 2 (hOCTN2) identified in Singaporean populations. Biochemical pharmacology. 82(11), 1692-9. [Abstract]
• Cui, P., Petrovic, N., Murray, M. (2011), The ω-3 epoxide of eicosapentaenoic acid inhibits endothelial cell proliferation by p38 MAP kinase activation and cyclin D1/CDK4 downregulation. British journal of pharmacology. 162(5), 1143-55. [Abstract]
• Zhou, F., Lee, A., Krafczyk, K., Zhu, L., Murray, M. (2011), Protein kinase C regulates the internalization and function of the human organic anion transporting polypeptide 1A2. British journal of pharmacology. 162(6), 1380-8. [Abstract]

2010

• Murray, M., Cui, P., Zhou, F. (2010), Roles of Mitogen-Activated Protein Kinases in the Regulation of CYP Genes. Current Drug Metabolism. 11(10), 850-858. [Abstract]
• Nebot, N., Crettol, S., d'Esposito, F., Tattam, B., Hibbs, D., Murray, M. (2010), Participation of CYP2C8 and CYP3A4 in the N-demethylation of imatinib in human hepatic microsomes. British Journal of Pharmacology. 161(5), 1059-1069. [Abstract]
• Ghassabian, S., Chetty, M., Tattam, B., Glen, J., Rahme, J., Stankovic, Z., Ramzan, I., Murray, M., McLachlan, A. (2010), The participation of cytochrome P450 3A4 in clozapine biotransformation is detected in people with schizophrenia by high-throughput in vivo phenotyping. Journal of clinical psychopharmacology. , 629-631. [Abstract]
• d'Esposito, F., Nebot, N., Edwards, R., Murray, M. (2010), Impaired irinotecan biotransformation in hepatic microsomal fractions from patients with chronic liver disease. British Journal of Clinical Pharmacology. 70(3), 400-408. [Abstract]
• Rong, X., Li, Y., Ebihara, K., Zhao, M., Kusakabe, T., Tomita, T., Murray, M., Nakao, K. (2010), Irbesartan treatment up-regulates hepatic expression of PPARalpha and its target genes in obese Koletsky (fa(k)/fa(k)) rats: a link to amelioration of hypertriglyceridaemia. British journal of pharmacology. 160(7), 17961807. [Abstract]
• Lee, A., Murray, M. (2010), Upregulation of human CYP2J2 in HepG2 cells by butylated hydroxyanisole is mediated by c-Jun and Nrf2. Molecular pharmacology. 77(6), 987-94. [Abstract]
• Rong, X., Li, Y., Ebihara, K., Zhao, M., Naowaboot, J., Kusakabe, T., Kuwahara, K., Murray, M., Nakao, K. (2010), Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-induced obesity, insulin resistance and fatty liver in mice. Diabetologia. 53, 1727–1731. [Abstract]
• Cui, P., Lee, A., Zhou, F., Murray, M. (2010), Impaired transactivation of the human CYP2J2 arachidonic acid epoxygenase gene in HepG2 cells subjected to nitrative stress. British journal of pharmacology. 159(7), 1440-1449. [Abstract]
• Li, Y., Saito, Y., Kuwahara, K., Rong, X., Kishimoto, I., Harada, M., Horiuchi, M., Murray, M., Nakao, K. (2010), Vasodilator therapy with hydralazine induces angiotensin AT receptor-mediated cardiomyocyte growth in mice lacking guanylyl cyclase-A. British Journal of Pharmacology. 159(5), 1133-1142. [Abstract]
• Rawling, T., Duke, C., Cui, P., Murray, M. (2010), Facile and stereoselective synthesis of (Z)-15-octadecenoic acid and (Z)-16-nonadecenoic acid: monounsaturated omega-3 fatty acids. Lipids. 45(2), 159-165. [Abstract]
• Crettol, S., Petrovic, N., Murray, M. (2010), Pharmacogenetics of phase I and phase II drug metabolism. Current Pharmaceutical Design. 16(2), 204-219. [Abstract]
• Murray, M. (2010), Cytochromes P450: Roles in the Biotransformation of Chemicals in Cigarette Smoke and Impact of Smoking Cessation on Concurrent Drug Therapy. Journal of Smoking Cessation. 5(2), 107-114.
• Petrovic, N., Murray, M. (2010), Using N,N,N',N'-tetramethyl-p-phenylenediamine (TMPD) to assay cyclooxygenase activity in vitro. In: Methods in Molecular Biology: Advanced Protocols in Oxidative Stress II. (pp.129-140).United States: Humana Press.
• Zhou, F., Zhu, L., Cui, P., Church, W., Murray, M. (2010), Functional characterization of nonsynonymous single nucleotide polymorphisms in the human organic anion transporter 4 (hOAT4). British journal of pharmacology. 159(2), 419-27. [Abstract]
• Toh, D., Yee, J., Koo, S., Murray, M., Lee, E. (2010), Genetic variations of the SLC22A5 gene in the Chinese and Indian populations of Singapore. Drug metabolism and pharmacokinetics. 25(1), 112-119. [Abstract]

2009

• Rong, X., Li, Y., Ebihara, K., Zhao, M., Aini, W., Kusakabe, T., Hirata, M., Miyamoto, L., Murray, M., Nakao, K. (2009), An adipose tissue-independent insulin-sensitizing action of telmisartan: a study in lipodystrophic mice. The Journal of pharmacology and experimental therapeutics. 331(3), 1096-1103. [Abstract]
• Chetty, M., d'Esposito, F., Zhang, W., Glen, J., Dore, G., Stankovic, Z., Edwards, R., Ramzan, I., Murray, M. (2009), In vitro and in vivo evaluation of the inhibition potential of risperidone toward clozapine biotransformation. British Journal of Clinical Pharmacology. 68(4), 574-579. [Abstract]
• He, L., Qi, Y., Rong, X., Jiang, J., Yang, Q., Yamahara, J., Murray, M., Li, Y. (2009), The Ayurvedic medicine Salacia oblonga attenuates diabetic renal fibrosis in rats: suppression of angiotensin II/AT1 signaling. Evidence-based complementary and alternative medicine : eCAM. doi:10.1093/ecam/nep, 1-13. [Abstract]
• Li, Y., Saito, Y., Kuwahara, K., Rong, X., Kishimoto, I., Harada, M., Adachi, Y., Nakanishi, M., Kinoshita, H., Horiuchi, M., Murray, M., Nakao, K. (2009), Guanylyl cyclase-A inhibits angiotensin II type 2 receptor-mediated pro-hypertrophic signaling in the heart. Endocrinology. 150(8), 3759-65. [Abstract]
• Xu, H., Murray, M., McLachlan, A. (2009), Influence of genetic polymorphisms on the pharmacokinetics and pharmaco-dynamics of sulfonylurea drugs. Current drug metabolism. 10(6), 643-658. [Abstract]
• Cui, P., Zhang, W., Hook, J., Tattam, B., Duke, C., Murray, M. (2009), Synthesis and NMR characterization of the methyl esters of eicosapentaenoic acid monoepoxides. Chemistry and physics of lipids. 159(1), 30-37. [Abstract]
• Ghassabian, S., Chetty, M., Tattam, B., Chem, M., Glen, J., Rahme, J., Stankovic, Z., Ramzan, I., Murray, M., McLachlan, A. (2009), A high-throughput assay using liquid chromatography-tandem mass spectrometry for simultaneous in vivo phenotyping of 5 major cytochrome p450 enzymes in patients. Therapeutic drug monitoring. 31(2), 239-246. [Abstract]

2008

• Zhang, W., D'Esposito, F., Edwards, R., Ramzan, I., Murray, M. (2008), Interindividual variation in relative CYP1A2/3A4 phenotype influences susceptibility of clozapine oxidation to cytochrome P450-specific inhibition in human hepatic microsomes. Drug metabolism and disposition: the biological fate of chemicals. 36(12), 2547-2555. [Abstract]
• D'Esposito, F., Tattam, B., Ramzan, I., Murray, M. (2008), A liquid chromatography/electrospray ionization mass spectrometry (LC-MS/MS) assay for the determination of irinotecan (CPT-11) and its two major metabolites in human liver microsomal incubations and human plasma samples. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 875(2), 522-530. [Abstract]
• Li, Y., Qi, Y., Kim, M., Xu, K., Huang, T., Rong, X., Murray, M., Yamahara, J. (2008), Increased renal collagen cross-linking and lipid accumulation in nephropathy of Zucker diabetic fatty rats. Diabetes/metabolism research and reviews. 24(6), 498-506. [Abstract]
• Rong, X., Kim, M., Su, N., Wen, S., Matsuo, Y., Yamahara, J., Murray, M., Li, Y. (2008), An aqueous extract of Salacia oblonga root, a herb-derived peroxisome proliferator-activated receptor-alpha activator, by oral gavage over 28 days induces gender-dependent hepatic hypertrophy in rats. Food and Chemical Toxicology. 46(6), 2165-2172. [Abstract]
• Xu, H., Williams, K., Liauw, W., Murray, M., Day, R., McLachlan, A. (2008), Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide. British journal of pharmacology. 153(7), 1579-86. [Abstract]
• Szymczak, M., Murray, M., Petrovic, N. (2008), Modulation of angiogenesis by omega-3 polyunsaturated fatty acids is mediated by cyclooxygenases. Blood. 111(7), 3514-3521. [Abstract]
• Murray, M. (2008), Modulation of Cytochromes P450 by Phytochemicals. In: Cytochromes P450: Role in the Metabolism and Toxicity of Drugs and other Xenobiotics. (pp.449-479).United Kingdom: RSC Publishing.
• Petrovic, N., Murray, M. (2008), Modulation of Tumor Angiogenesis by Polyunsaturated Fatty Acids: What is the Mechanism?. In: Oncogene Proteins: Structure, Functions and Analyses. (pp.117-138).United States: Nova Science Publishers Inc.

2007

• Zhang, W., Ramzan, I., Murray, M. (2007), IMPAIRED MICROSOMAL OXIDATION OF THE ATYPICAL ANTIPSYCHOTIC AGENT CLOZAPINE IN HEPATIC STEATOSIS. The Journal of pharmacology and experimental therapeutics. 322(2), 770-7. [Abstract]
• Chetty, M., Murray, M. (2007), CYP-mediated clozapine interactions: how predictable are they?. Current Drug Metabolism. 8(4), 307-313. [Abstract]
• Murray, M. (2007), Role of signalling systems in the effects of dietary factors on the expression of mammalian CYPs. Expert Opinion on Drug Metabolism & Toxicology. 3(2), 185-196. [Abstract]
• Fiala-Beer, E., Lee, A., Murray, M. (2007), Regulation of the rat CYP4A2 gene promoter by c-Jun and octamer binding protein-1. The International Journal of Biochemistry & Cell Biology. 39(6), 1235-1247. [Abstract]